What J&J's authorized Covid-19 shot means for the US vaccination campaign
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Saturday
February 04, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SATURDAY, FEBRUARY 04, 2023
What J&J's authorized Covid-19 shot means for the US vaccination campaign

Analysis

Reuters
28 February, 2021, 08:40 am
Last modified: 28 February, 2021, 08:48 am

Related News

  • Incepta Pharma abandons Covid vaccine plan
  • Moderna reports positive results for RSV vaccine
  • J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose

What J&J's authorized Covid-19 shot means for the US vaccination campaign

The following is how it fits into the vaccination effort with the two other authorized immunizations from Pfizer Inc/BioNTech SE and Moderna Inc

Reuters
28 February, 2021, 08:40 am
Last modified: 28 February, 2021, 08:48 am
What J&J's authorized Covid-19 shot means for the US vaccination campaign

Johnson & Johnson's one-shot Covid-19 vaccine received US authorization on Saturday and will start being administered to Americans within days.

The following is how it fits into the vaccination effort with the two other authorized immunizations from Pfizer Inc/BioNTech SE and Moderna Inc.

Is J&J's Vaccine As Effective As The Other Two?

The Pfizer/BioNTech and Moderna vaccines, which both use new messenger RNA technology, showed efficacy of around 95% percent in preventing illness in large trials, while J&J's showed efficacy of around 66%.

However, the trials had important differences, making comparison difficult. Pfizer and Moderna focused on efficacy against mild-to-moderate sickness, while J&J's trial looked for efficacy against moderate-to-severe Covid-19.

J&J's trial was conducted later and included significant numbers of participants in regions where highly transmissible new variants of the virus were circulating, potentially subjecting its shot to a more rigorous test.

Importantly, J&J's vaccine was about as effective against severe illness and hospitalization as the other vaccines and, like the others, was 100% effective in preventing Covid-19-related death in the trial.

All three vaccines have a similar range of short-lived side effects, including fatigue, aches, injection site soreness, nausea and fever, mostly mild-to-moderate.

If J&J's Shot Is Less Effective, Why Should I Get It?

J&J's vaccine is a single shot. Pfizer/BioNTech and Moderna vaccines each require two shots three or four weeks apart.

J&J's shot is extremely effective at preventing people exposed to Covid-19 from getting severely ill or dying, as well as offering protection against milder cases.

US authorizes J&J's Covid-19 vaccine, making it third available

"These vaccines are the path to getting your life back," said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security. "These are vaccines you should not hesitate to get when offered."

J&J's vaccine is one of the few that has been tested in clinical trails against the worrisome virus variant first discovered in South Africa. It demonstrated an ability to provide protection against severe disease and death even for those infected with that variant. Pfizer and Moderna have only tested their vaccines against the variant in the lab and believe they will remain protective.

Do I Have A Choice Of Vaccine?

Experts say that for the next couple of months vaccine supplies will be too scarce for healthcare providers to offer a choice. Most vaccination sites will receive only one of the three vaccines at any given time.

Patients who prefer a specific vaccine can ask healthcare providers which one they have on hand. Later in the year, greater availability of shots could result in more patient choice, but health experts strongly advise taking whichever vaccine you can get.

How Many Doses Of J&J's New Shot Will Be Available?

J&J said it expects to ship nearly 4 million doses in the first week, and shipments could begin late Sunday or early Monday.

Details about J&J Covid-19 vaccine authorized in US

J&J expects to deliver a total of 20 million shots by the end of March and as many as 100 million doses by mid-year.

The federal government, through distributor McKesson Corp, will ship J&J's shots to states and territories around the United States. It will also deliver them to select pharmacies and community health centers to make sure they reach underserved populations.

Between J&J, Pfizer/BioNTech and Moderna, the United States is on track to receive 240 million doses by the end of March, enough to fully inoculate 130 million Americans. The drugmakers have agreed to send 700 million doses of their vaccines by the end of July, more than enough to vaccinate all Americans.

Coronavirus chronicle / Top News

Coronavirus Vaccine / covid-19 vaccine / Johnson & Johnson Covid-19 Vaccine / Johnson & Johnson’s Covid-19 vaccine / Johnson & Johnson / J&J / J&J Covid-19 Vaccine / Pfizer Covid-19 Vaccine / Pfizer-BioNTech vaccine / Pfizer coronavirus vaccine / Moderna Covid-19 Vaccine / Moderna Vaccine / Moderna Inc

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Cash-strapped banks fail to maintain emergency cash
  • The Adani Group headquarters in Ahmedabad. Photo: Bloomberg
    Adani Enterprises shelves $122 million bond plan
  • Is the IMF to blame for growing pressure on your wallet?
    Is the IMF to blame for growing pressure on your wallet?

MOST VIEWED

  • Why 2012 reforms were not done is a million-dollar question
    Why 2012 reforms were not done is a million-dollar question
  • Is the IMF to blame for growing pressure on your wallet?
    Is the IMF to blame for growing pressure on your wallet?
  • Dr Mustafa K Mujeri. Illustration: TBS
    Strengthen social safety net before phasing out subsidies
  • Dr Salehuddin Ahmed. Illustration: TBS
    Reforms in banking must to sustain financial sector
  • Muhammad Abdul Mazid, Former chairman, National Board of Revenue. TBS Sketch
    Raising tax-GDP ratio, withdrawing exemptions tough now
  • Photo: Bloomberg
    The China-Russia friendship is too big to fail

Related News

  • Incepta Pharma abandons Covid vaccine plan
  • Moderna reports positive results for RSV vaccine
  • J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose

Features

Sketch: TBS

Say 'Salud' before your salad main course

7h | Food
Coots running. Photo: Enam Ul Haque

Cute Coot of Baikka Beel: 'And yet he was as bald as a coot'

1h | Panorama
With only one government run specialised cancer hospital in the capital — the National Institute Of Cancer Research and Hospital (NICRH) in Mohakhali — patients have no option but to resort to private hospitals. Photo: Noor A Alam.

Cancer care: Medical treatment and beyond

8h | Panorama
Andy Mukherjee. Sketch: TBS

What makes India's billionaires' support special for Adani

1d | Panorama

More Videos from TBS

Concord launches new plant to produce environment friendly bricks

Concord launches new plant to produce environment friendly bricks

4h | TBS Stories
How Asif Khan would invest his fresh funds right now

How Asif Khan would invest his fresh funds right now

4h | TBS Markets
A proper price formula can help investors to plan big

A proper price formula can help investors to plan big

1d | TBS Round Table
Rumors about Sarika that everyone thinks are true

Rumors about Sarika that everyone thinks are true

1d | TBS Entertainment

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
Photo: Collected
Energy

8 Ctg power plants out of production

3
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

6
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net